| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 654379 | ANTINEOPLASTIC-654379 | 0.0480633950058471 | 0.06746953 |
| NSC 663286 | 7-Chloro-6-N-(2-fluoroethylamino)-5,8-quinolinedione | 0.0480633950058471 | 0.25266464 |
| NSC 678144 | 4H-1,3,6,2-Dioxazaphosphocinium, 4-hexadecyltetrahydro- 2,6,6-trimethyl-, bromide, 2-oxide | 0.0480633950058471 | -0.18779675 |
| NSC 696862 | 1H-1,4,7-Triazonine-1,4-diacetic acid, octahydro- | 0.0480633950058471 | 0.16118814 |
| NSC 697748 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(4-nitrophenyl)- | 0.0480633950058471 | 0.50385426 |
| NSC 703315 | Null | 0.0480633950058471 | 0.30224661 |
| NSC 704556 | Null | 0.0480633950058471 | -0.049702995 |
| NSC 724063 | (3-nitro-benzylidene-hydrazinocarbonylmethylsulfanyl)-acetic acid (3-nitro-benzylidene)-hydrazide | 0.0480633950058471 | -0.10586539 |
| NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.0480633950058471 | 0.20370081 |
| NSC 732517 | Dasatinib | 0.0480633950058471 | -0.3178619 |